How to balance cardiometabolic benefits and risks of statins

Journal of the American College of Cardiology

Volumn 61, Issue 18, 2013, Pages 1932-1933

  Koh, Kwang Kon ^a  

^a Gachon University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; SIMVASTATIN; TRIACYLGLYCEROL;

BODY MASS; CARDIOVASCULAR DISEASE; DIABETES MELLITUS; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG MEGADOSE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INSULIN RESISTANCE; LETTER; LOW DRUG DOSE; META ANALYSIS (TOPIC); NEW ONSET DIABETES; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR;

CARDIOVASCULAR DISEASES; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; FEMALE; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; PYRROLES; SIMVASTATIN;

EID: 84876952687     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.01.068     Document Type: Letter

References (5)

1. D.D. Waters, J.E. Ho, S.M. Boekholdt Cardiovascular event reduction versus new-onset diabetes during atorvastatin therapy: effect of baseline risk factors for diabetes J Am Coll Cardiol 61 2013 148 152
2. K.K. Koh, M.J. Quon, S.H. Han, Y. Lee, S.J. Kim, E.K. Shin Atorvastatin causes insulin resistance and increases ambient glycemia in hypercholesterolemic patients J Am Coll Cardiol 55 2010 1209 1216
3. D. Preiss, S.R. Seshasai, P. Welsh Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis JAMA 305 2011 2556 2564
4. P.M. Ridker, A. Pradhan, J.G. MacFadyen, P. Libby, R.J. Glynn Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial Lancet 380 2012 565 571
5. S. Lim, I. Sakuma, M.J. Quon, K.K. Koh Potentially important considerations in choosing specific statin treatments to reduce overall morbidity and mortality Int J Cardiol 2012 Nov 15 [E-pub ahead of print].